Also trades as: BXRX (NASDAQ) · $vol 0M
BXRXQ OTC
Baudax Bio, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -90.0%
1Y: -90.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+17.5% ▲
Gross Profit
-$6M
-320.5% ▼
Operating Income
-$57M
-198.9% ▼
Net Income
-$59M
-197.4% ▼
EPS (Diluted)
$-177.30
+50.9% ▲
EBITDA
-$34M
+32.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $493K | $1M | $1M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +119.1% | +17.5% |
| Cost of Revenue | $0 | $0 | $2M | $2M | $7M |
| Gross Profit | $0 | $0 | -$1M | -$1M | -$6M |
| Gross Margin | — | — | -251.3% | -126.4% | -452.3% |
| R&D Expenses | $36M | $20M | $9M | $3M | $4M |
| SG&A Expenses | $29M | $27M | $43M | $45M | $24M |
| Operating Expenses | $74M | $33M | $74M | $18M | $51M |
| Operating Income | -$74M | -$33M | -$75M | -$19M | -$57M |
| Operating Margin | — | — | -15169.6% | -1759.8% | -4477.0% |
| Interest Expense | $0 | $0 | $1M | $2M | $0 |
| Income Before Tax | -$74M | -$33M | -$76M | -$20M | -$59M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$74M | -$33M | -$76M | -$20M | -$59M |
| Net Margin | — | — | -15436.1% | -1830.5% | -4633.2% |
| EPS (Diluted) | $-11361.35 | $-4872.07 | $-5714.80 | $-361.16 | $-177.30 |
| EBITDA | -$65M | -$32M | -$72M | -$50M | -$34M |
| Shares Outstanding | 6484 | 6679 | 13315 | 54738 | 331615 |